Cell therapies continue to rise in usage across the cancer landscape, with chimeric antigen receptor (CAR) T-cell therapies, mesenchymal stem cell therapies, natural killer cell therapies, and tumor-infiltrating lymphocytes falling under this umbrella.
For the full article click here: Pathologists Anticipate Evolving Role Using Allogeneic Cell Therapies